Reducing air pollution exposure to lower blood pressure in NYC public housing residents
Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents
This study is testing if using portable air cleaners can help lower blood pressure for adults with high blood pressure living in public housing in New York City by reducing air pollution indoors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 440 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05874479 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of indoor portable air cleaners (PACs) on reducing fine particulate matter (PM2.5) exposure and lowering systolic blood pressure among adults living with hypertension in New York City public housing. Participants will be assigned to receive either an active PAC or a sham PAC to assess the effectiveness of this intervention. The study aims to provide evidence on the relationship between air quality and blood pressure, potentially leading to improved health outcomes for residents affected by air pollution.
Who should consider this trial
Good fit: Ideal candidates include self-reported nonsmokers living in nonsmoking households who are adults with hypertension residing in NYC public housing.
Not a fit: Patients with severe hypertension, established cardiovascular disease, or significant barriers to technology use may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to effective interventions for lowering blood pressure in populations exposed to high levels of air pollution.
How similar studies have performed: Previous studies have shown promising results in using air cleaners to improve indoor air quality and potentially lower blood pressure, making this approach both relevant and tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * self-reported nonsmokers living in a nonsmoking household. * adults living with hypertension (HTN) from NYC public housing. Exclusion Criteria: * History of major known arrhythmias (e.g. atrial flutter or fibrillation, ventricular tachycardia). * Screening systolic BP ≥160 mm Hg or diastolic BP ≥100 mm Hg (i.e. severe hypertension by the 2017 ACC/AHA BP guideline). * A change in drug regimen in the prior 2 weeks or a planned change in drug regimen during the first 30 days for those taking antihypertensive medication. * Current smoking or living with an active smoker who smokes indoors * Planned travel out of NYC for ≥2 weeks in next 6 months * Incarcerated * Pregnant * Unable/unwilling to consent * Established cardiovascular disease * End-stage renal disease (chronic kidney disease stage IV or on dialysis) * Barrier to technology use (e.g., visual or hearing impairment) * Lung disease requiring oxygen * Cancer receiving treatment
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Jonathan Newman — NYU Langone Health
- Study coordinator: Jonathan Newman
- Email: AirPressureNYC@nyulangone.org
- Phone: (212) 263-9393
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.